Medicina (Apr 2022)

Comparison of Choroidal Thickness, Foveal Avascular Zone, and Macular Capillary Density in Macular Edema Secondary to Branch Retinal Vein Occlusion Treated with Ranibizumab or Aflibercept—A Prospective Study

  • Yu-Te Huang,
  • I Wang,
  • Chun-Ju Lin,
  • Chun-Ting Lai,
  • Ning-Yi Hsia,
  • Huan-Sheng Chen,
  • Peng-Tai Tien,
  • Henry Bair,
  • Jane-Ming Lin,
  • Wen-Lu Chen,
  • Chang-He Chen,
  • Wen-Chuan Wu,
  • Yi-Yu Tsai

DOI
https://doi.org/10.3390/medicina58040540
Journal volume & issue
Vol. 58, no. 4
p. 540

Abstract

Read online

This prospective comparative case series aims to compare best-corrected visual acuity (BCVA), retinal microvasculature, and retinal structural changes in patients treated with either ranibizumab or aflibercept for macular edema (ME) secondary to treatment-naïve branch retinal vein occlusion (BRVO) by optical coherence tomography angiography (OCTA). Ten patients were enrolled with macular capillary density of the superficial capillary plexus (SCP) and deep capillary plexus (DCP) and foveal avascular zone (FAZ) measured in both eyes before and after treatment. Final central retinal thickness and BCVA improved significantly (p p p = 0.0001, p p p p < 0.0001). OCTA offered further qualitative and quantitative evaluation of treatment-naïve BRVO. Judging by OCTA parameters, not only in the diseased eye but also in the fellow eye, DCP density of BRVO sectors was the most predictive factor of final visual outcome.

Keywords